 |
인쇄하기
취소
|
Diovan soon to be top anti-hypertension drug in Korea.
Novartis Korea established their sales promotional plan for Diovan, an anti-hypertension drug, at the top rank next year.
Novartis Korea said on May 4 that in competition with Cozaar and Aprovel in the ARB anti-hypertension drug markets Diovan would get the top seller soon, which was already accomplished at the general hospital markets.
Currently, Diovan is competing with Cozaar and Aprov...
Novartis Korea said on May 4 that in competition with Cozaar and Aprovel in the ARB anti-hypertension drug markets Diovan would get the top seller soon, which was already accomplished at the general hospital markets.
Currently, Diovan is competing with Cozaar and Aprov...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.